medrxiv Subject Collection: Pain Medicine Palliative Medicine
http://medrxiv.org
This feed contains articles for medRxiv Subject Collection "Pain Medicine Palliative Medicine"
medrxivmedrxivhttps://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png
http://medrxiv.org
<![CDATA[
"We don't complain; it's just part of being a woman": frequency, knowledge, and sociocultural beliefs about dysmenorrhoea in a South African university cohort
]]>
https://www.medrxiv.org/content/10.64898/2026.06.10.26355353v1?rss=1
2026-06-10doi:10.64898/2026.06.10.26355353Cold Spring Harbor Laboratory2026-06-10
<![CDATA[
Safety and Tolerability of Low Intensity Focused Ultrasound to the Anterior Insula in Patients with Fibromyalgia
]]>
https://www.medrxiv.org/content/10.64898/2026.06.01.26354382v1?rss=1
2026-06-09doi:10.64898/2026.06.01.26354382Cold Spring Harbor Laboratory2026-06-09
<![CDATA[
Associations between initial treatments for acute low back pain and opioid use disorder and overdose risk in Medicaid patients
]]>
https://www.medrxiv.org/content/10.64898/2026.06.05.26355003v1?rss=1
50 daily Morphine Milligram Equivalents (MME) (118.1%, 95% CI: 99.2%, 137.0%). Lower-dose, short-duration opioids ([≤] 50 MME, [≤] 7 days) were also associated with elevated risk, though substantially smaller in magnitude (20.8%, 95% CI: 13.8%, 27.9%). In contrast, non-pharmacologic, non-interventional therapies were associated with reduced OUD and overdose diagnosis risk, with physical therapy demonstrating the largest relative reduction of 34.0% (95% CI: -40.9%, -27.1%).
DiscussionIn opioid-naive Medicaid patients with acute low back pain, initial non-pharmacologic treatment was associated with reduced OUD and overdose diagnosis risk. Gabapentinoids and opioids were each associated with increased risk; for opioids, the degree of risk increased with higher doses and durations. These results support guideline recommendations favoring non-pharmacologic treatment as first-line therapy and indicate the importance of cautious prescribing when pharmacologic treatment is considered.
]]>2026-06-08doi:10.64898/2026.06.05.26355003Cold Spring Harbor Laboratory2026-06-08
<![CDATA[
Validation of the Fremantle Perineal Awareness Questionnaire (FrePAQ) in women with Chronic Pelvic Pain
]]>
https://www.medrxiv.org/content/10.64898/2026.06.05.26354913v1?rss=1
2026-06-08doi:10.64898/2026.06.05.26354913Cold Spring Harbor Laboratory2026-06-08
<![CDATA[
Comparing cannabinoid extracts for treating cancer-related symptoms: a randomized placebo-controlled, triple-blind aggregate n-of-1 clinical trial
]]>
https://www.medrxiv.org/content/10.64898/2026.05.31.26354558v1?rss=1
2026-06-02doi:10.64898/2026.05.31.26354558Cold Spring Harbor Laboratory2026-06-02
<![CDATA[
Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey
]]>
https://www.medrxiv.org/content/10.64898/2026.05.29.26354422v1?rss=1
2026-06-01doi:10.64898/2026.05.29.26354422Cold Spring Harbor Laboratory2026-06-01
<![CDATA[
A Pilot Randomized Controlled Trial to Evaluate the Preliminary Efficacy of PAL-CHW-PDAC, a Digitally Enhanced CHW-led Intervention to Facilitate Stepped Palliative Care in Patients with Pancreatic Cancer.
]]>
https://www.medrxiv.org/content/10.64898/2026.05.20.26353748v1?rss=1
2026-05-22doi:10.64898/2026.05.20.26353748Cold Spring Harbor Laboratory2026-05-22
<![CDATA[
Impact of GLP-1 Receptor Agonists on Chronic Low Back Pain in Patients with Obesity: A Prospective Pilot Cohort Study
]]>
https://www.medrxiv.org/content/10.64898/2026.05.20.26353666v1?rss=1
2026-05-22doi:10.64898/2026.05.20.26353666Cold Spring Harbor Laboratory2026-05-22
<![CDATA[
Comparing palliative care quality between designated and non-designated cancer hospitals: A secondary analysis of bereaved family surveys
]]>
https://www.medrxiv.org/content/10.64898/2026.05.14.26353232v1?rss=1
2026-05-19doi:10.64898/2026.05.14.26353232Cold Spring Harbor Laboratory2026-05-19
<![CDATA[
Real-World Changes in Movement-Evoked Pain and Gait in Adults With Knee Osteoarthritis
]]>
https://www.medrxiv.org/content/10.64898/2026.05.11.26352918v1?rss=1
2026-05-14doi:10.64898/2026.05.11.26352918Cold Spring Harbor Laboratory2026-05-14
<![CDATA[
Quantifying Biopsychosocial Risk Factor Domains for Chronic Pain Treatment Outcomes: An Umbrella Review with De Novo Meta-Analyses, Formal Uncertainty Propagation, and the Pain Amplifier Loop Framework (PALF)
]]>
https://www.medrxiv.org/content/10.64898/2026.05.05.26352397v1?rss=1
2026-05-12doi:10.64898/2026.05.05.26352397Cold Spring Harbor Laboratory2026-05-12
<![CDATA[
Identifying community nurses contributions to end-of-life care: an online survey study
]]>
https://www.medrxiv.org/content/10.64898/2026.05.08.26352717v1?rss=1
2026-05-12doi:10.64898/2026.05.08.26352717Cold Spring Harbor Laboratory2026-05-12
<![CDATA[
Activity-Induced Changes in Pain and Knee Range of Motion in Adults With Knee Osteoarthritis
]]>
https://www.medrxiv.org/content/10.64898/2026.05.04.26352365v1?rss=1
2026-05-10doi:10.64898/2026.05.04.26352365Cold Spring Harbor Laboratory2026-05-10
<![CDATA[
Prompt-engineering improves clinical safety of large language models for opioid equipotency conversion
]]>
https://www.medrxiv.org/content/10.64898/2026.05.06.26352590v1?rss=1
2026-05-08doi:10.64898/2026.05.06.26352590Cold Spring Harbor Laboratory2026-05-08
<![CDATA[
Challenging deficient inhibitory conditioned pain modulation as common chronic pain feature and detectable subgroup characteristic
]]>
https://www.medrxiv.org/content/10.64898/2026.05.01.26352197v1?rss=1
2026-05-03doi:10.64898/2026.05.01.26352197Cold Spring Harbor Laboratory2026-05-03
<![CDATA[
Nociceptive stimulation suppresses spinal beta oscillations in awake human epidural recordings
]]>
https://www.medrxiv.org/content/10.64898/2026.04.21.26351212v1?rss=1
2026-04-30doi:10.64898/2026.04.21.26351212Cold Spring Harbor Laboratory2026-04-30
<![CDATA[
Contributions to palliative and end-of-life care by community health nursing services: improving care through national and regional service evaluations
]]>
https://www.medrxiv.org/content/10.64898/2026.04.21.26351027v1?rss=1
2026-04-29doi:10.64898/2026.04.21.26351027Cold Spring Harbor Laboratory2026-04-29
<![CDATA[
Efficacy of virtual reality treatment of phantom leg pain: Results of a randomized clinical trial
]]>
https://www.medrxiv.org/content/10.64898/2026.04.20.26350810v1?rss=1
2026-04-28doi:10.64898/2026.04.20.26350810Cold Spring Harbor Laboratory2026-04-28
<![CDATA[
Acceptance of approaching death in cancer and non-cancer patients according to general practitioners; a European Study in Primary Care
]]>
https://www.medrxiv.org/content/10.64898/2026.04.23.26351589v1?rss=1
2026-04-28doi:10.64898/2026.04.23.26351589Cold Spring Harbor Laboratory2026-04-28
<![CDATA[
Graph-Based Synthetic EHR Generation with Improved Quality-Privacy Trade-offs for Opioid Use Disorder Prediction
]]>
https://www.medrxiv.org/content/10.64898/2026.04.24.26351704v1?rss=1
2026-04-27doi:10.64898/2026.04.24.26351704Cold Spring Harbor Laboratory2026-04-27
<![CDATA[
Recovering Clinical Detail in AI-Generated Responses for Low Back Pain Through Prompt Design
]]>
https://www.medrxiv.org/content/10.64898/2026.04.21.26351437v1?rss=1
2026-04-23doi:10.64898/2026.04.21.26351437Cold Spring Harbor Laboratory2026-04-23
<![CDATA[
Benefit take-up in the last year of life: a population-based study using linked data for England and Wales
]]>
https://www.medrxiv.org/content/10.64898/2026.04.10.26350614v1?rss=1
2026-04-11doi:10.64898/2026.04.10.26350614Cold Spring Harbor Laboratory2026-04-11
<![CDATA[
Meta-analytic Evidence for Four Amplifier Loops in Chronic Pain Chronification: The Pain Amplifier Loop Framework (PALF) as a Conceptual Risk Index for Prospective Validation
]]>
https://www.medrxiv.org/content/10.64898/2026.04.07.26350260v1?rss=1
500,000 participants. As a meta-analytic synthesis rather than a fitted prediction model, the PALF requires prospective multicenter validation with individual patient data before clinical application. PROSPERO registration: CRD420261360881.
]]>2026-04-07doi:10.64898/2026.04.07.26350260Cold Spring Harbor Laboratory2026-04-07
<![CDATA[
Beyond intensity: Pain distribution shapes healthcare- and treatment-seeking beliefs in individuals with and without clinical pain
]]>
https://www.medrxiv.org/content/10.64898/2026.04.02.26349577v1?rss=1
2026-04-04doi:10.64898/2026.04.02.26349577Cold Spring Harbor Laboratory2026-04-04
<![CDATA[
PainWaive: A Consumer-grade Digitally Delivered EEG Neurofeedback Intervention for Chronic Low Back Pain
]]>
https://www.medrxiv.org/content/10.64898/2026.03.26.26349247v1?rss=1
2026-04-01doi:10.64898/2026.03.26.26349247Cold Spring Harbor Laboratory2026-04-01
<![CDATA[
Association of Suzetrigine With Postoperative Outcomes Versus Opioid Analgesics: Propensity-Matched Study
]]>
https://www.medrxiv.org/content/10.64898/2026.03.29.26349666v1?rss=1
Age 18 years) who underwent surgery and received suzetrigine were compared with patients who underwent surgery and received opioids. Propensity score matching (1:1) performed to match cohorts based on demographic factors (age, gender, racial/ethnic status), social determinants of health (ICD-10 Z55-Z65), family histories of substance abuse and psychiatric disorders (Z81.x), surrogate measures of prior healthcare utilization, and pre-existing clinical severity using Elixhauser-Charlson comorbidity proxies (hypertensive diseases [I10-I15], diabetes mellitus [E08-E13], ischemic heart disease [I22-I25], and chronic pulmonary disease [J42-J47]). Matching also included behavioral risk factors (tobacco use and physical inactivity) and body mass index (BMI). Following matching, there were 2,221 patients in each cohort. The primary outcome assessed within one year after surgery was ED utilization, depression, anxiety, post-traumatic stress disorder (PTSD) and sleep disorders. Risk estimates and survival analyses were used to compare the outcomes.
ResultsIn propensity-matched analyses, suzetrigine use was associated with a reduction in multiple psychiatric outcomes and healthcare utilization compared to opioid analgesics. There was less ED utilization in the suzetrigine cohort (5.9% v 13.1%, RR 0.45, p< .001). The psychiatric outcomes were also lower in the suzetrigine cohort than the opioid cohort, including depression (3.1% v 4.7%, RR 0.65, p= .005), anxiety (4.7% v 7.2%, RR 0.65, p< .001), PTSD (0.5% v 1.4%, RR 0.36, p= .002), and sleep disorders (4.2% v 6.0%, RR 0.71, p= .008). The survival analysis suggested an earlier onset of psychiatric diagnosis among the opioid recipients.
ConclusionIn a matched real-world cohort of surgical patients, suzetrigine use was associated with lower short-term rates of selected postoperative outcomes compared with opioid analgesics.
]]>2026-03-31doi:10.64898/2026.03.29.26349666Cold Spring Harbor Laboratory2026-03-31
<![CDATA[
Dementia and End-of-Life Shared Decision-Making Among Older US Adults
]]>
https://www.medrxiv.org/content/10.64898/2026.03.27.26349555v1?rss=1
2026-03-30doi:10.64898/2026.03.27.26349555Cold Spring Harbor Laboratory2026-03-30
<![CDATA[
Pulsed Electromagnetic Fields in Chronic Pain Management: a KDM6B-Mediated Modulation Mechanism Hypothesis
]]>
https://www.medrxiv.org/content/10.64898/2026.03.23.26348899v1?rss=1
2026-03-25doi:10.64898/2026.03.23.26348899Cold Spring Harbor Laboratory2026-03-25
<![CDATA[
Structural and Functional Alterations of the Dorsolateral Prefrontal Cortex Across Chronic Pain Cohorts
]]>
https://www.medrxiv.org/content/10.64898/2026.03.24.26349122v1?rss=1
2026-03-25doi:10.64898/2026.03.24.26349122Cold Spring Harbor Laboratory2026-03-25
<![CDATA[
Working memory in chronic pain: evidence for task-specific rather than global differences
]]>
https://www.medrxiv.org/content/10.64898/2026.03.20.26348805v1?rss=1
2026-03-25doi:10.64898/2026.03.20.26348805Cold Spring Harbor Laboratory2026-03-25